Docile 2000 IU tvrde kapsule ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

docile 2000 iu tvrde kapsule

abiogen pharma s.p.a., via meucci 36, ospedaletto, pisa, italija - kolekalciferol - kapsula, tvrda - urbroj: jedna tvrda kapsula sadrži 50 mikrograma kolekalciferola (vitamina d3), što odgovara 2000 iu

Docile 25 000 IU tvrde kapsule ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

docile 25 000 iu tvrde kapsule

abiogen pharma s.p.a., via meucci 36, ospedaletto, pisa, italija - kolekalciferol - kapsula, tvrda - urbroj: jedna tvrda kapsula sadrži 625 mikrograma kolekalciferola (vitamina d3), što odgovara 25 000 iu

Docile 6000 IU tvrde kapsule ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

docile 6000 iu tvrde kapsule

abiogen pharma s.p.a., via meucci 36, ospedaletto, pisa, italija - kolekalciferol - kapsula, tvrda - urbroj: jedna tvrda kapsula sadrži 150 mikrograma kolekalciferola (vitamina d3), što odgovara 6000 iu

Docile 10 000 IU/ml oralne kapi, otopina ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

docile 10 000 iu/ml oralne kapi, otopina

abiogen pharma s.p.a., via meucci 36, ospedaletto, pisa, italija - kolekalciferol - oralne kapi, otopina - urbroj: jedan ml oralnih kapi (40 kapi) sadrži 0,25 mg kolekalciferola (vitamina d3), što odgovara 10 000 iu jedna kap sadrži 0,00625 mg kolekalciferola (vitamina d3), što odgovara 250 iu

INFANRIX Hexa ≥ 30 i.j./0.5 mL+ ≥ 40 i.j./0.5 mL+ 25 µg/0.5 mL+ 25 µg/0.5 mL+ 8 µg/0.5 mL+ 10 µg/0.5 mL+ 40 AgU/0.5 mL+ 8 AgU/0. বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

infanrix hexa ≥ 30 i.j./0.5 ml+ ≥ 40 i.j./0.5 ml+ 25 µg/0.5 ml+ 25 µg/0.5 ml+ 8 µg/0.5 ml+ 10 µg/0.5 ml+ 40 agu/0.5 ml+ 8 agu/0.

evropa lijek pharma d.o.o. - пропорциональному protiv difterije, hemofilus utjecaj b, pertusisa, poliomijelitisa, tetanusa, hepatitisa b - prašak i suspenzija za suspenziju za injekciju - ≥ 30 i.j./0.5 ml+ ≥ 40 i.j./0.5 ml+ 25 µg/0.5 ml+ 25 µg/0.5 ml+ 8 µg/0.5 ml+ 10 µg/0.5 ml+ 40 agu/0.5 ml+ 8 agu/0.5 ml+ 32 agu/0 - 0,5 ml suspenzije za injekciju (1 doza) sadrži: ne manje od 30 i.j. toksoid difterije, adsorbovani ne manje od 40 i.j. toksoid tetanusa, adsorbovani 25 mcg pertusis toksoid, adsorbovani 25 mcg filamentozni hemaglutinin, adsorbovani 8 mcg pertaktin, adsorbovani 10 mcg površinski antigen hepatitis b virusa 40 dantigen jedinica polio virus, inaktivirani, tip 1 8 dantigen jedinica polio virus, inaktivirani, tip 2 32 dantigen jedinica polio virus, in aktivirani, tip 3 10 mcg polisaharid hemofilusa tip b (konjugovan na toksoid tetanusa), adsorbovani

RENVELA 800 mg 800 mg/1 tableta film tableta বসনিয়া ও হার্জেগোভিনা - ক্রোয়েশীয় - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

renvela 800 mg 800 mg/1 tableta film tableta

amicus pharma d.o.o. - sevelamer - film tableta - 800 mg/1 tableta - 1 film tableta sadrži: 800 mg sevelamerkarbonata

BindRen ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

bindren

mitsubishi pharma europe ltd - colestilan - hiperfosfatemija - lijekovi za liječenje hiperkalemije i hiperfosfatemije - liječenje hiperfosfatemije u odraslih bolesnika s kroničnom bolesti bubrega, stupanj 5, koji primaju hemodijalizu ili peritonealnu dijalizu.

Edistride ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

edistride

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. osim drugih lijekova za liječenje šećerne bolesti tipa 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Forxiga ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

forxiga

astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. osim drugih lijekova za liječenje šećerne bolesti tipa 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

Qtern ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

qtern

astra zeneca ab - Саксаглиптин, dapagliflozin пропандиола monohidrat - diabetes mellitus, type 2; diabetes mellitus; nutritional and metabolic diseases; metabolic diseases; glucose metabolism disorders - lijekovi koji se koriste u dijabetesu - qtern, fiksnih doza kombinacija саксаглиптин i dapagliflozin, pojavljuje se kod odraslih u dobi od 18 godina i stariji sa dijabetesom tip 2:za poboljšanje glikemijski kontrole pri метформина i/ili sulfonilureje (su) i jedan od однокомпонентных od qtern ne pružaju adekvatnu glikemijski kontrole kada je već лечусь sa slobodnim kombinacijom dapagliflozin i саксаглиптин. (sl. sekcija 4. 2, 4. 4, 4. 5 i 5. 1 prema dostupnim podacima o kombinaciji studirao.